Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for rare gynecologic indications: peritoneal metastases from breast and endometrial cancer

Abstract Background Peritoneal metastasis (PM) in patients with breast (BC) and endometrial cancer (EC) is rare and treatment options are limited. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) has demonstrated efficacy against PM from various cancers, but its efficacy in BC/EC patients is...

Full description

Bibliographic Details
Main Authors: Günther A. Rezniczek, Urs Giger-Pabst, Omar Thaher, Clemens B. Tempfer
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Cancer
Subjects:
PIPAC
Peritoneal metastasis
Breast cancer
Endometrial cancer
Tumor regression
Online Access:http://link.springer.com/article/10.1186/s12885-020-07627-1

Internet

http://link.springer.com/article/10.1186/s12885-020-07627-1

Similar Items